These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 660521)

  • 21. Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution.
    Gordon MS; Chowhan ZT
    J Pharm Sci; 1987 Dec; 76(12):907-9. PubMed ID: 3440935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of dissolution rate of hydrochlorothiazide via solid dispersion.
    Abd el-Fattah S; Boraie NA; Hassan HM
    Pharmazie; 1986 Nov; 41(11):790-3. PubMed ID: 3562513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.
    Hughey JR; Keen JM; Miller DA; Kolter K; Langley N; McGinity JW
    Eur J Pharm Sci; 2013 Mar; 48(4-5):758-66. PubMed ID: 23348153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the dissolution behaviour of tablets containing the drug in a polyethyleneglycol solid dispersion with direct compressed tablets.
    Kinget R
    Pharm Acta Helv; 1989; 64(3):90-3. PubMed ID: 2726990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of medicinal carbon tablets with different saccharides as binders.
    Yamamoto K; Ito A; Machida Y
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1058-60. PubMed ID: 19801858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
    Ojarinta R; Saarinen J; Strachan CJ; Korhonen O; Laitinen R
    Eur J Pharm Biopharm; 2018 Nov; 132():112-126. PubMed ID: 30248394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
    Goddeeris C; Willems T; Van den Mooter G
    Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):244-7. PubMed ID: 14758011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyethylene glycol as a binder for tablets.
    Shah RC; Raman PV; Sheth PV
    J Pharm Sci; 1977 Nov; 66(11):1551-2. PubMed ID: 915729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced dissolution of sildenafil citrate as dry foam tablets.
    Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
    Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: Development, characterization and stability evaluation.
    Khan I; Yousaf S; Subramanian S; Albed Alhnan M; Ahmed W; Elhissi A
    Int J Pharm; 2018 Mar; 538(1-2):250-262. PubMed ID: 29337185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
    Labib GS
    Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
    Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
    AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions.
    van Drooge DJ; Hinrichs WL; Frijlink HW
    J Control Release; 2004 Jul; 97(3):441-52. PubMed ID: 15212876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 4: Effect of disintegrants.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jun; 30(6):377-82. PubMed ID: 1161788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.